Versant Capital Management »

Mineralys Therapeutics shares owned by Versant Capital Management

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $813 63 12.90
2023-12-31 $542 63 8.60
2023-06-30 $546 32 17.06

More positions owned by Versant Capital Management

Avantis International Equity Etf Etf (AVDE)
Vanguard Emerging Markets Government Bond Etf Etf (VWOB)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Ishares S&p Global Energy Etf (IXC)
Microsoft Stock (MSFT)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)
Vanguard Total Stk Mkt Etf (VTI)
Exxon Mobil Corp Stock (XOM)
Vaneck Gold Miners Etf Etf (GDX)
Dimensional Us Marketwide Value Etf Etf (DFUV)
Spdr Gold Minishares Trust Etf (GLDM)
Avantis U.s. Equity Etf Etf (AVUS)
Spdr S&p Global Natural Resources Etf Etf (GNR)

View all positions for Versant Capital Management

Top funds holding Mineralys Therapeutics

Samsara BioCapital
RA Capital Management
Braidwell
Sr One Capital Management
BlackRock
Laurion Capital Management
Vanguard Group
Sphera Funds Management
Franklin Resources
Blue Owl Capital Holdings
Millennium Management
Point72 Asset Management
Charles Schwab Investment Management
Citadel Advisors
Two Sigma Investments

View all funds holding Mineralys Therapeutics